moxifloxacin has been researched along with Pericementitis in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khan, IN; Khan, IU; Li, A; Shahzad, Y; Yousaf, AM | 1 |
| Beg, S; Dhiman, S; Jain, A; Sharma, RK; Sharma, T; Singh, B | 1 |
| Ardila, CM; Bedoya-García, JA; Hernández-Casas, C | 1 |
| Cardona, N; Cossio-Pérez, R; Molina, D; Patiño, J; Rocha-Roa, C | 1 |
| Cachovan, G; Eick, S; Nietzsche, S; Sculean, A; Tsaousoglou, P | 1 |
| Al-Nawas, B; d'Hoedt, B; Karbach, J; Mouratidou, A | 1 |
| Eick, S; Pfister, W; Sachse, S; Schmidt, KH; Schmitt, A | 1 |
| Eick, S; Pfister, W | 1 |
| Ardanza-Trevijano, B; Canut, A; Isla, A; Labora, A; Pedraz, JL; Rodríguez-Gascón, A; Solinís, MA | 1 |
| Alvarez, M; Diz, P; Limeres, J; Potel, C; Tomás, I; Tomás, M; Velasco, D | 1 |
1 review(s) available for moxifloxacin and Pericementitis
| Article | Year |
|---|---|
[Pharmacokinetic/pharmacodynamic analysis of antibiotic therapy in dentistry and stomatology].
Topics: Algorithms; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Area Under Curve; Aza Compounds; Bacterial Infections; Clindamycin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluoroquinolones; Fusobacterium nucleatum; Humans; Microbial Sensitivity Tests; Mouth Diseases; Moxifloxacin; Peptostreptococcus; Periodontitis; Porphyromonas gingivalis; Prevotella intermedia; Quinolines; Time Factors; Viridans Streptococci | 2005 |
1 trial(s) available for moxifloxacin and Pericementitis
| Article | Year |
|---|---|
Effects on clinical outcomes of adjunctive moxifloxacin versus amoxicillin plus metronidazole in periodontitis patients harboring Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, and Tannerella forsythia: exploratory analyses from a clinic
Topics: Adult; Aggregatibacter actinomycetemcomitans; Amoxicillin; Anti-Bacterial Agents; Humans; Metronidazole; Moxifloxacin; Periodontal Attachment Loss; Periodontal Pocket; Periodontitis; Porphyromonas gingivalis; Tannerella; Tannerella forsythia | 2021 |
8 other study(ies) available for moxifloxacin and Pericementitis
| Article | Year |
|---|---|
Gellan Gum-Based Bilayer Mucoadhesive Films Loaded with Moxifloxacin Hydrochloride and Clove Oil for Possible Treatment of Periodontitis.
Topics: Adhesiveness; Administration, Buccal; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Clove Oil; Delayed-Action Preparations; Drug Liberation; Gram-Negative Bacteria; Gram-Positive Bacteria; Moxifloxacin; Oils, Volatile; Periodontitis; Polysaccharides, Bacterial | 2021 |
Stimuli Responsive In Situ Gelling Systems Loaded with PLGA Nanoparticles of Moxifloxacin Hydrochloride for Effective Treatment of Periodontitis.
Topics: Animals; Anti-Bacterial Agents; Delayed-Action Preparations; Drug Delivery Systems; Female; Gels; Moxifloxacin; Nanoparticles; Particle Size; Periodontitis; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Treatment Outcome; Viscosity | 2020 |
In silico study of Moxifloxacin derivatives with possible antibacterial activity against a resistant form of DNA gyrase from Porphyromonas gingivalis.
Topics: Anti-Bacterial Agents; Computer Simulation; DNA Gyrase; Drug Resistance, Bacterial; Molecular Docking Simulation; Molecular Structure; Moxifloxacin; Periodontitis; Porphyromonas gingivalis | 2018 |
Antibacterial activity of moxifloxacin on bacteria associated with periodontitis within a biofilm.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria; Bacterial Physiological Phenomena; Biofilms; Doxycycline; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Microbial Viability; Moxifloxacin; Ofloxacin; Periodontitis; Quinolines | 2014 |
Antibiotic susceptibility of cocultures in polymicrobial infections such as peri-implantitis or periodontitis: an in vitro model.
Topics: Acetamides; Actinobacillus Infections; Aggregatibacter actinomycetemcomitans; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; Capnocytophaga; Coculture Techniques; Coinfection; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Linezolid; Metronidazole; Microbial Interactions; Minocycline; Moxifloxacin; Oxazolidinones; Penicillin G; Peptostreptococcus; Peri-Implantitis; Periodontitis; Quinolines; Sulbactam | 2011 |
In vitro antibacterial activity of fluoroquinolones against Porphyromonas gingivalis strains.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacteroidaceae Infections; DNA Gyrase; DNA Primers; DNA Topoisomerase IV; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Periodontitis; Porphyromonas gingivalis; Quinolines; Reverse Transcriptase Polymerase Chain Reaction | 2004 |
Efficacy of antibiotics against periodontopathogenic bacteria within epithelial cells: an in vitro study.
Topics: Aggregatibacter actinomycetemcomitans; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Clindamycin; Colony Count, Microbial; Doxycycline; Fluoroquinolones; Humans; Intracellular Space; KB Cells; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Periodontitis; Periodontium; Porphyromonas gingivalis; Quinolines; Streptococcus constellatus; Time Factors | 2004 |
Susceptibility of oral obligate anaerobes to telithromycin, moxifloxacin and a number of commonly used antibacterials.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; Blood; Clindamycin; Culture Media; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Anaerobic Bacteria; Hemin; Humans; Ketolides; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Penicillin Resistance; Periodontitis; Quinolines; Saliva; Vitamin K | 2007 |